NAVB | Navidea Biopharmaceuticals, Inc. Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2022	2021	2020	2019	2018	2017
Total Assets	4.37 Million	6.64 Million	7.75 Million	4.15 Million	7 Million	20.78 Million
Total Current Assets	3.2 Million	5.38 Million	6.52 Million	2.91 Million	4.97 Million	13.83 Million
Cash And Short Term Investments	1.99 Million	4.23 Million	2.67 Million	1.04 Million	4.27 Million	4.59 Million
Cash and Cash Equivalents	1.99 Million	4.23 Million	2.67 Million	1.04 Million	3.47 Million	4.59 Million
Short Term Investments	-	-	-	-	799.27 Thousand	1.79 Million
Net Receivables	630.00	92.99 Thousand	2.98 Million	901.33 Thousand	21.15 Thousand	8.13 Million
Inventory	427.34 Thousand	151.15 Thousand	169.79 Thousand	-901.33 Thousand	1.00	-
Other Current Assets	1.2 Million	1.15 Million	3.85 Million	1.86 Million	678.21 Thousand	1.1 Million
Total Non-Current Assets	1.16 Million	1.26 Million	1.22 Million	1.23 Million	2.03 Million	6.94 Million
Net PPE	155.64 Thousand	248.7 Thousand	382.25 Thousand	311.89 Thousand	162.17 Thousand	236.7 Thousand
Good Will And Intangible Assets	1 Million	785.65 Thousand	620.24 Thousand	385.41 Thousand	428.49 Thousand	458.15 Thousand
Good Will	-	-	-	-	-	-
Intangible Assets	1 Million	785.65 Thousand	620.24 Thousand	385.41 Thousand	428.49 Thousand	458.15 Thousand
Long-Term Investments	-	-	15.27 Million	-	-	4.8 Million
Tax Assets	-	-	-15.27 Million	-	-	-4.8 Million
Other Non Current Assets	11.77 Thousand	227.19 Thousand	227.19 Thousand	537.81 Thousand	1.44 Million	6.25 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	12.51 Million	6.02 Million	5.71 Million	5.03 Million	4.61 Million	8.73 Million
Total Current Liabilities	9.94 Million	5.29 Million	4.71 Million	3.81 Million	3.37 Million	8.06 Million
Account Payables	2.12 Million	1.42 Million	1.16 Million	1.11 Million	424.71 Thousand	855.04 Thousand
Tax Payables	-	-	-	-	-	-
Short Term Debt	562.58 Thousand	729.14 Thousand	1.04 Million	556.5 Thousand	316.07 Thousand	2.35 Million
Deferred Revenue	800 Thousand	700 Thousand	700 Thousand	700 Thousand	866.93 Thousand	-855.04 Thousand
Other Current Liabilities	6.45 Million	2.44 Million	1.81 Million	1.45 Million	1.77 Million	5.71 Million
Total Non Current Liabilities	2.57 Million	720.28 Thousand	996 Thousand	1.21 Million	1.23 Million	664.7 Thousand
Long-Term Debt	1.87 Million	20.28 Thousand	296 Thousand	512.34 Thousand	468.49 Thousand	588.09 Million
Deferred Revenue Non Current	700 Thousand	700 Thousand	700 Thousand	700 Thousand	700 Thousand	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1312.00	20.28 Thousand	296 Thousand	512.34 Thousand	532.54 Thousand	-587.42 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	-8.14 Million	624.74 Thousand	2.04 Million	-880.98 Thousand	2.39 Million	12.04 Million
Stock Holders Equity	-8.43 Million	-106.55 Thousand	1.31 Million	-1.61 Million	1.72 Million	11.37 Million
Common Stock	223.68 Thousand	221.27 Thousand	218.14 Thousand	210.23 Thousand	200.39 Thousand	162.2 Thousand
Retained Earnings	-388 Million	-370.78 Million	-359.05 Million	-347.67 Million	-336.72 Million	-319.9 Million
Accumulated other comprehensive income	-	-	-4.97 Million	902.00	-730.00	-2396.00
Common Stock Equity	-8.43 Million	-106.55 Thousand	1.31 Million	-1.61 Million	1.72 Million	11.37 Million
Capital Lease Obligation	20.28 Thousand	296 Thousand	590.95 Thousand	762.89 Thousand	589.17 Thousand	695.3 Million
Total Investments	-	-	15.27 Million	-	799.27 Thousand	1.79 Million
Total Debt	2.43 Million	749.43 Thousand	1.33 Million	1.06 Million	316.07 Thousand	2.35 Million
Net Debt	438.44 Thousand	-3.48 Million	-1.33 Million	21.69 Thousand	-3.15 Million	-2.23 Million

Breakdown	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 FY	2022 Q3
Total Assets	5.69 Million	8.21 Million	2.36 Million	4.37 Million	4.37 Million	6.25 Million
Total Current Assets	4.5 Million	7 Million	1.19 Million	3.2 Million	3.2 Million	5.09 Million
Cash And Short Term Investments	3.86 Million	6.14 Million	33.79 Thousand	1.99 Million	1.99 Million	4.6 Million
Cash and Cash Equivalents	3.86 Million	6.14 Million	33.79 Thousand	1.99 Million	1.99 Million	4.6 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	30.87 Thousand	44.71 Thousand	31.04 Thousand	630.00	630.00	155.18 Thousand
Inventory	460.74 Thousand	460.74 Thousand	460.63 Thousand	427.34 Thousand	427.34 Thousand	193.8 Thousand
Other Current Assets	146.59 Thousand	355.21 Thousand	672.06 Thousand	1.2 Million	1.2 Million	150.12 Thousand
Total Non-Current Assets	1.19 Million	1.21 Million	1.17 Million	1.16 Million	1.16 Million	1.15 Million
Net PPE	119.38 Thousand	141.96 Thousand	147.72 Thousand	155.64 Thousand	155.64 Thousand	185.49 Thousand
Good Will And Intangible Assets	1.06 Million	1.06 Million	1.01 Million	1 Million	1 Million	941.24 Thousand
Good Will	-	-	-	-	-	-
Intangible Assets	1.06 Million	1.06 Million	1.01 Million	1 Million	1 Million	941.24 Thousand
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	11.77 Thousand	11.77 Thousand	11.77 Thousand	11.77 Thousand	11.77 Thousand	31.77 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	8.67 Million	9 Million	11.91 Million	12.51 Million	12.51 Million	10.92 Million
Total Current Liabilities	7.97 Million	8.3 Million	9.25 Million	9.94 Million	9.94 Million	8.43 Million
Account Payables	2.07 Million	2 Million	3.17 Million	2.12 Million	2.12 Million	1.73 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	1.25 Million	1.33 Million	353.44 Thousand	562.58 Thousand	562.58 Thousand	27.34 Thousand
Deferred Revenue	800 Thousand	800 Thousand	800 Thousand	800 Thousand	800 Thousand	800 Thousand
Other Current Liabilities	3.84 Million	4.15 Million	4.92 Million	6.45 Million	6.45 Million	5.86 Million
Total Non Current Liabilities	700.26 Thousand	700.53 Thousand	2.66 Million	2.57 Million	2.57 Million	2.49 Million
Long-Term Debt	269.00	534.00	1.96 Million	1.87 Million	1.87 Million	1.79 Million
Deferred Revenue Non Current	700 Thousand	700 Thousand	700 Thousand	700 Thousand	700 Thousand	700 Thousand
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	700 Thousand	700 Thousand	1.96 Million	1312.00	1312.00	-
Other Liabilities	-	-	-	-	-	-
Total Equity	-2.98 Million	-786.58 Thousand	-9.54 Million	-8.14 Million	-8.14 Million	-4.66 Million
Stock Holders Equity	-3.27 Million	-1.07 Million	-9.84 Million	-8.43 Million	-8.43 Million	-4.95 Million
Common Stock	291.08 Thousand	287.14 Thousand	223.84 Thousand	223.68 Thousand	223.68 Thousand	223.14 Thousand
Retained Earnings	-385.9 Million	-383.65 Million	-389.47 Million	-388 Million	-388 Million	-384.52 Million
Accumulated other comprehensive income	-3.27 Million	-1.07 Million	-	-	-	-
Common Stock Equity	-3.27 Million	-1.07 Million	-9.84 Million	-8.43 Million	-8.43 Million	-4.95 Million
Capital Lease Obligation	10.69 Thousand	19.56 Thousand	11.29 Thousand	20.28 Thousand	20.28 Thousand	29.03 Thousand
Total Investments	-	-	-	-	-	-
Total Debt	1.25 Million	1.33 Million	2.31 Million	2.43 Million	2.43 Million	1.82 Million
Net Debt	-2.6 Million	-4.8 Million	2.28 Million	438.44 Thousand	438.44 Thousand	-2.78 Million

Balance Sheet Charts

Kamdhenu Limited

KAMDHENU

Full Analysis

Annual Balance Sheets
CAE Inc.

CAE

Full Analysis

Annual Balance Sheets
Yuancheng Environment Co., Ltd.

603388

Full Analysis

Annual Balance Sheets
Furuya Metal Co., Ltd.

7826

Full Analysis

Annual Balance Sheets
Ocugen, Inc.

OCGN

Full Analysis

Annual Balance Sheets
Sun Pharma Advanced Research Company Limited

SPARC

Full Analysis

Annual Balance Sheets

Global Stocks Search

Navidea Biopharmaceuticals, Inc. (NAVB)

Annual Balance Sheets

Balance Sheet Charts

Kamdhenu Limited

CAE Inc.

Yuancheng Environment Co., Ltd.

Furuya Metal Co., Ltd.

Ocugen, Inc.

Sun Pharma Advanced Research Company Limited